Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3761 Target Snapshot

Beta-glucosidase · SINGLE PROTEIN · Homo sapiens

202Compounds
36Assays
2Approved Drugs
212.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9HCG7. Use UniProt Q9HCG7 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9HCG7 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Beta-glucosidase as ChEMBL target CHEMBL3761, mapped to UniProt Q9HCG7. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Beta-glucosidase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL3761
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9HCG7
Non-lysosomal glucosylceramidase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Beta-glucosidase is the right protein anchor across sources, using UniProt Q9HCG7 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNon-lysosomal glucosylceramidase
UniProt AccessionQ9HCG7
Component TypeProtein
Sequence Length927 aa

Non-lysosomal glucosylceramidase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Beta-glucosidase, mapped to UniProt Q9HCG7. ChEMBL maps the protein component as Non-lysosomal glucosylceramidase. Sequence length is 927 aa.

Mapped IDQ9HCG7
Review nameBeta-glucosidase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase III
3
Phase II
Assay Mix

Activity Type Distribution

IC50209.0
KI3.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3354624 10.1 IC50 0.08 Preclinical
CHEMBL3354625 10.1 IC50 0.08 Preclinical
CHEMBL3354627 10.1 IC50 0.08 Preclinical
CHEMBL3354634 10.0 IC50 0.1 Preclinical
CHEMBL3354635 10.0 IC50 0.1 Preclinical
CHEMBL3354626 9.92 IC50 0.12 Preclinical
CHEMBL574645 9.52 IC50 0.3 Preclinical
CHEMBL1651630 9.4 IC50 0.4 Preclinical
CHEMBL3354636 9.4 IC50 0.4 Preclinical
CHEMBL3354041 9.3 IC50 0.5 Preclinical
Distribution

pChEMBL Value Distribution

7
5.0
1
5.5
6
6.0
17
6.5
16
7.0
22
7.5
22
8.0
31
8.5
20
9.0
2
9.5
pChEMBL
Approved Drugs

Approved Drugs

MIGLUSTAT
CHEMBL1029
Approved 2002
Assay Landscape

Assay Landscape

36
Total Assays
154
Tested Compounds
1
Assay Types
Binding — 36 assays, 154 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 25 131 7.5
assay format 6 6 6.9
cell-based format 5 17 7.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine